T2 Biosystems T2 Biosystems Advancing Pipeline, Accelerating Instrument Placement Strategy Premium The company is working to transition its instruments sold in the US from COVID-19 testing to sepsis testing and increase its installed base. T2 Biosystems Q1 Revenues Nearly Triple Product revenues were up 345 percent, as the firm increased US sepsis test utilization by 85 percent and sold four T2Dx instruments. T2 Biosystems Q4 Revenues Jump 152 Percent on Strong Product Sales The company said that it sold 57 T2Dx instruments in 2020, including 47 in the US, more than doubling its US installed base. T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates The firm also announced the amendment of the terms of a loan with CRG, a global healthcare investor. T2 Biosystems Q3 Revenues Triple, Beat Estimates The firm also more than tripled its product sales year over year, and its CEO said he considered the quarter to be "transformational." Sep 30, 2020 BARDA Exercises $10.5M Option on T2 Bio Contract Aug 31, 2020 T2 Biosystems Gets FDA EUA for SARS-CoV-2 Molecular Diagnostic Test Aug 13, 2020 HelixBind Aims to Circumvent Culture With Rapid Technology to Detect Bloodstream Infections Premium Aug 11, 2020 T2 Biosystems Q2 Revenues Up 41 Percent, Beat Estimates Jul 1, 2020 T2 Biosystems Preliminary Q2 Revenues Up About 40 Percent; Firm Launches COVID-19 Test Jun 19, 2020 People in the News: Geoffrey Oxnard, Christopher O'Connell, Thierry Bernard, More Jun 17, 2020 T2 Biosystems Regains Compliance With Nasdaq Listing Requirements May 5, 2020 T2 Biosystems Q1 Revenues Jump 43 Percent Apr 9, 2020 T2 Biosystems Receives Nasdaq Warning Letter Mar 24, 2020 T2 Biosystems Preliminary Q1 Revenues Spike; Firm Suspends 2020 Guidance, Licenses COVID-19 Test Feb 25, 2020 New T2 Biosystems CEO Plans to Shrink Costs, Sharpen Sales Strategy Premium Feb 24, 2020 T2 Biosystems Q4 Revenues Jump 71 Percent, Miss Analyst Estimates Jan 9, 2020 T2 Biosystems Preliminary Q4 Revenues up 67 Percent, Firm Announces CEO Transition Nov 20, 2019 T2 Biosystems Gets CE Mark for Direct-From-Blood Antimicrobial Resistance Panel Nov 12, 2019 T2 Biosystems Q3 Revenues Drop 36 Percent; Firm Suffers Ransom Cyberattack Sep 25, 2019 T2 Biosystems Inks Distribution Deal in Puerto Rico, US Virgin Islands Sep 13, 2019 BARDA Contract Win, Unprecedented CMS Incentive Expected to Catalyze T2 Biosystems Growth Premium Jul 18, 2017 T2 Biosystems Receives CE Mark for Bacterial Panel May 2, 2017 T2 Biosystems' Gain in Q1 Product Sales Offset by Decline in Research Revenue Feb 13, 2017 T2 Biosystems Q4 Revenues Fall 10 Percent Load More Breaking News Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.